Increasing studies have demonstrated that HNF4A, FOSL2, and GATA4 showed aberrant expression in various malignant tumors, playing a role in promoting or inhibiting malignancies [8, 23–25], and our study results were consistent with these studies. This evidence concerns the gene FOSL2 and cancer.